This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussing the role of AhR in inflammatory diseases including ulcerative colitis, and how that translates to EQ504, a potent and selective AhR modulator from Equillium

Ticker(s): EQ

Who's the expert?

Institution: Harvard

  • Professor of Neurology at Harvard
  • Associate Scientist, Brigham and Women's Hospital
  • The Quintana Lab combines advanced genomic and proteomic tools with innovative experimental models (e.g. zebrafish and humanized mice) to study the regulation of the immune response in the central nervous system, with a focus on the following areas: Regulation of CNS local immunity, Regulation of the adaptive immune response, and Role of environmental factors in MS

Interview Goal
Discuss how AhR activation can promote both barrier function and anti-inflammatory pathways, highlighting it as an attractive therapeutic target. 

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.